205 related articles for article (PubMed ID: 19376605)
1. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.
Yiu WH; Pan CJ; Mead PA; Starost MF; Mansfield BC; Chou JY
J Hepatol; 2009 Nov; 51(5):909-17. PubMed ID: 19376605
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
[TBL] [Abstract][Full Text] [Related]
3. Liver-directed gene therapy for murine glycogen storage disease type Ib.
Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology and gene therapy for glycogen storage disease type Ib.
Chou JY; Cho JH; Kim GY; Mansfield BC
J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
[TBL] [Abstract][Full Text] [Related]
5. Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.
Yiu WH; Pan CJ; Allamarvdasht M; Kim SY; Chou JY
Gene Ther; 2007 Feb; 14(3):219-26. PubMed ID: 17006547
[TBL] [Abstract][Full Text] [Related]
6. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
[TBL] [Abstract][Full Text] [Related]
7. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
Chou JY; Jun HS; Mansfield BC
J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review.
Cho JH; Weinstein DA; Lee YM
J Inherit Metab Dis; 2021 Jan; 44(1):118-128. PubMed ID: 32474930
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.
Cho JH; Lee YM; Starost MF; Mansfield BC; Chou JY
J Inherit Metab Dis; 2019 May; 42(3):459-469. PubMed ID: 30637773
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for type I glycogen storage diseases.
Chou JY; Mansfield BC
Curr Gene Ther; 2007 Apr; 7(2):79-88. PubMed ID: 17430128
[TBL] [Abstract][Full Text] [Related]
11. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
Chen LY; Shieh JJ; Lin B; Pan CJ; Gao JL; Murphy PM; Roe TF; Moses S; Ward JM; Lee EJ; Westphal H; Mansfield BC; Chou JY
Hum Mol Genet; 2003 Oct; 12(19):2547-58. PubMed ID: 12925567
[TBL] [Abstract][Full Text] [Related]
12. Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
Brooks ED; Landau DJ; Everitt JI; Brown TT; Grady KM; Waskowicz L; Bass CR; D'Angelo J; Asfaw YG; Williams K; Kishnani PS; Koeberl DD
J Inherit Metab Dis; 2018 Nov; 41(6):965-976. PubMed ID: 30043186
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.
Kim SY; Jun HS; Mead PA; Mansfield BC; Chou JY
Blood; 2008 Jun; 111(12):5704-11. PubMed ID: 18420828
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
Chen LY; Pan CJ; Shieh JJ; Chou JY
Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
[TBL] [Abstract][Full Text] [Related]
15. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
[TBL] [Abstract][Full Text] [Related]
16. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration.
Kim GY; Lee YM; Kwon JH; Jun HS; Chou J
Biochem Biophys Res Commun; 2017 Jan; 482(4):569-574. PubMed ID: 27864142
[TBL] [Abstract][Full Text] [Related]
17. Glycogen storage disease type Ib: role of glucose-6-phosphate transporter in cell metabolism and function.
Sim SW; Weinstein DA; Lee YM; Jun HS
FEBS Lett; 2020 Jan; 594(1):3-18. PubMed ID: 31705665
[TBL] [Abstract][Full Text] [Related]
18. Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy.
Yiu WH; Lee YM; Peng WT; Pan CJ; Mead PA; Mansfield BC; Chou JY
Mol Ther; 2010 Jun; 18(6):1076-84. PubMed ID: 20389290
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of an inducible mouse model for glycogen storage disease type Ib.
Raggi F; Pissavino AL; Resaz R; Segalerba D; Puglisi A; Vanni C; Antonini F; Del Zotto G; Gamberucci A; Marcolongo P; Bosco MC; Grillo F; Mastracci L; Eva A
J Inherit Metab Dis; 2018 Nov; 41(6):1015-1025. PubMed ID: 29967951
[TBL] [Abstract][Full Text] [Related]
20. Recombinant AAV-directed gene therapy for type I glycogen storage diseases.
Chou JY; Mansfield BC
Expert Opin Biol Ther; 2011 Aug; 11(8):1011-24. PubMed ID: 21504389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]